Seoulin Bioscience Financials
| 038070 Stock | KRW 7,340 230.00 3.23% |
Seoulin |
Understanding current and past Seoulin Bioscience Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Seoulin Bioscience's financial statements are interrelated, with each one affecting the others. For example, an increase in Seoulin Bioscience's assets may result in an increase in income on the income statement.
Please note, the presentation of Seoulin Bioscience's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Seoulin Bioscience's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Seoulin Bioscience's management manipulating its earnings.
Seoulin Bioscience Stock Summary
Seoulin Bioscience competes with Busan Industrial, UNISEM, Finebesteel, Shinhan Inverse, and Fine Besteel. ,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company was founded in 1984 and is headquartered in Seongnam, South Korea. SeouLin is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7038070009 |
| Business Address | 700 Daewangpangyo ro |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.seoulin.co.kr |
| Phone | (82) 31 628 3007 |
| Currency | KRW - South Korean Won |
You should never invest in Seoulin Bioscience without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Seoulin Stock, because this is throwing your money away. Analyzing the key information contained in Seoulin Bioscience's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Seoulin Bioscience Key Financial Ratios
Seoulin Bioscience's financial ratios allow both analysts and investors to convert raw data from Seoulin Bioscience's financial statements into concise, actionable information that can be used to evaluate the performance of Seoulin Bioscience over time and compare it to other companies across industries.| Return On Equity | 10.81 | |||
| Return On Asset | 0.0554 | |||
| Number Of Employees | 91 | |||
| Beta | 0.76 | |||
| Z Score | 3.0 |
Seoulin Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Seoulin Bioscience's current stock value. Our valuation model uses many indicators to compare Seoulin Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Seoulin Bioscience competition to find correlations between indicators driving Seoulin Bioscience's intrinsic value. More Info.Seoulin Bioscience CoLtd is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.01 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Seoulin Bioscience CoLtd is roughly 195.19 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Seoulin Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Seoulin Bioscience's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Seoulin Bioscience CoLtd Systematic Risk
Seoulin Bioscience's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Seoulin Bioscience volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Seoulin Bioscience CoLtd correlated with the market. If Beta is less than 0 Seoulin Bioscience generally moves in the opposite direction as compared to the market. If Seoulin Bioscience Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Seoulin Bioscience CoLtd is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Seoulin Bioscience is generally in the same direction as the market. If Beta > 1 Seoulin Bioscience moves generally in the same direction as, but more than the movement of the benchmark.
Seoulin Bioscience January 3, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Seoulin Bioscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Seoulin Bioscience CoLtd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Seoulin Bioscience CoLtd based on widely used predictive technical indicators. In general, we focus on analyzing Seoulin Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Seoulin Bioscience's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.07 | |||
| Information Ratio | 0.0218 | |||
| Maximum Drawdown | 44.21 | |||
| Value At Risk | (7.08) | |||
| Potential Upside | 7.47 |
Complementary Tools for Seoulin Stock analysis
When running Seoulin Bioscience's price analysis, check to measure Seoulin Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seoulin Bioscience is operating at the current time. Most of Seoulin Bioscience's value examination focuses on studying past and present price action to predict the probability of Seoulin Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seoulin Bioscience's price. Additionally, you may evaluate how the addition of Seoulin Bioscience to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |